Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

DNA repair inhibitors as radiosensitizers in human lung cells

Kamila Ďurišová, Lucie Čecháková, Petr Jošt, Zuzana Šinkorová, Adéla Kmochová, Jaroslav Pejchal, Martin Ondrej, Jiřina Vávrová, Aleš Tichý

. 2018 ; 16 (1) : 66-74.

Jazyk angličtina Země Česko

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18019110

The aim of this study was to compare the effects of DNA repair inhibitors in the context of radio-sensitization of human lung cells. The radio-sensitizing effects of NU7441 (1 mM), an inhibitor of DNA-dependent protein kinase (DNA-PK); KU55933 (10 μM), an inhibitor of ataxia-telangiectasia mutated kinase (ATM); and VE-821 (10 μM), an inhibitor of ATM-related kinase (ATR) were tested by the xCELLigence system for monitoring proliferation, fluorescence microscopy for DNA damage detection, flow-cytometry for cell cycle and apoptosis analysis and western blotting and ELISA for determination of DNA repair proteins. We employed normal human lung fibroblasts (NHLF, p53-wild-type) and non-small cell lung cancer cells (H1299, p53-negative). DNA-PK inhibition (by NU7441) in combination with ionizing radiation (IR) increased the number of double strand breaks (DSB), which persisted 72 h after irradiation in both cell lines. Additionally, NU7441 and KU55933 in combination with IR caused G2-arrest. ATR inhibitor (VE-821) together with IR markedly inhibited proliferation and induced G2/M arrest accompanied by apoptosis in H1299, but not in NHLF cells, and thus diminished DNA-repair of tumour cells but not normal lung fibroblasts. Our findings indicate that ATR inhibition could be a promising therapeutic strategy in p53-deficient lung tumours.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc18019110
003      
CZ-PrNML
005      
20180830183522.0
007      
ta
008      
180528s2018 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jab.2017.10.008 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Ďurišová, Kamila $7 xx0225104 $u University of Defence in Brno, Faculty of Military Health Sciences in Hradec Králové, Department of Radiobiology, Hradec Králové, Czech Republic
245    10
$a DNA repair inhibitors as radiosensitizers in human lung cells / $c Kamila Ďurišová, Lucie Čecháková, Petr Jošt, Zuzana Šinkorová, Adéla Kmochová, Jaroslav Pejchal, Martin Ondrej, Jiřina Vávrová, Aleš Tichý
504    __
$a Literatura
520    9_
$a The aim of this study was to compare the effects of DNA repair inhibitors in the context of radio-sensitization of human lung cells. The radio-sensitizing effects of NU7441 (1 mM), an inhibitor of DNA-dependent protein kinase (DNA-PK); KU55933 (10 μM), an inhibitor of ataxia-telangiectasia mutated kinase (ATM); and VE-821 (10 μM), an inhibitor of ATM-related kinase (ATR) were tested by the xCELLigence system for monitoring proliferation, fluorescence microscopy for DNA damage detection, flow-cytometry for cell cycle and apoptosis analysis and western blotting and ELISA for determination of DNA repair proteins. We employed normal human lung fibroblasts (NHLF, p53-wild-type) and non-small cell lung cancer cells (H1299, p53-negative). DNA-PK inhibition (by NU7441) in combination with ionizing radiation (IR) increased the number of double strand breaks (DSB), which persisted 72 h after irradiation in both cell lines. Additionally, NU7441 and KU55933 in combination with IR caused G2-arrest. ATR inhibitor (VE-821) together with IR markedly inhibited proliferation and induced G2/M arrest accompanied by apoptosis in H1299, but not in NHLF cells, and thus diminished DNA-repair of tumour cells but not normal lung fibroblasts. Our findings indicate that ATR inhibition could be a promising therapeutic strategy in p53-deficient lung tumours.
650    _2
$a nemalobuněčný karcinom plic $x genetika $x radioterapie $7 D002289
650    _2
$a oprava DNA $x účinky léků $7 D004260
650    _2
$a enzymy opravy DNA $x antagonisté a inhibitory $x genetika $7 D045643
650    _2
$a radiosenzibilizující látky $x farmakologie $x izolace a purifikace $x terapeutické užití $7 D011838
650    _2
$a nádorové buňky kultivované $x účinky léků $x účinky záření $7 D014407
650    _2
$a kultivované buňky $x účinky záření $7 D002478
650    _2
$a fibroblasty $x účinky záření $7 D005347
650    _2
$a proliferace buněk $x účinky záření $7 D049109
650    _2
$a techniky in vitro $7 D066298
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Čecháková, Lucie $7 xx0225214 $u University of Defence in Brno, Faculty of Military Health Sciences in Hradec Králové, Department of Radiobiology, Hradec Králové, Czech Republic
700    1_
$a Jošt, Petr $7 xx0225106 $u University of Defence in Brno, Faculty of Military Health Sciences in Hradec Králové, Department of Toxicology and Military Pharmacy, Hradec Králové, Czech Republic; University Hospital Hradec Králové, Biomedical Research Centre, Hradec Králové, Czech Republic
700    1_
$a Šinkorová, Zuzana, $d 1963- $7 xx0106471 $u University of Defence in Brno, Faculty of Military Health Sciences in Hradec Králové, Department of Radiobiology, Hradec Králové, Czech Republic
700    1_
$a Kmochová, Adéla $7 xx0225217 $u University of Defence in Brno, Faculty of Military Health Sciences in Hradec Králové, Department of Radiobiology, Hradec Králové, Czech Republic
700    1_
$a Pejchal, Jaroslav $7 xx0102560 $u University of Defence in Brno, Faculty of Military Health Sciences in Hradec Králové, Department of Radiobiology, Hradec Králové, Czech Republic; University of Defence in Brno, Faculty of Military Health Sciences in Hradec Králové, Department of Toxicology and Military Pharmacy, Hradec Králové, Czech Republic
700    1_
$a Ondrej, Martin $7 xx0225221 $u University of Defence in Brno, Faculty of Military Health Sciences in Hradec Králové, Department of Radiobiology, Hradec Králové, Czech Republic
700    1_
$a Vávrová, Jiřina, $d 1946- $7 xx0004363 $u University of Defence in Brno, Faculty of Military Health Sciences in Hradec Králové, Department of Radiobiology, Hradec Králové, Czech Republic
700    1_
$a Tichý, Aleš, $d 1980- $7 xx0135624 $u University of Defence in Brno, Faculty of Military Health Sciences in Hradec Králové, Department of Radiobiology, Hradec Králové, Czech Republic; University Hospital Hradec Králové, Biomedical Research Centre, Hradec Králové, Czech Republic
773    0_
$t Journal of applied biomedicine $x 1214-021X $g Roč. 16, č. 1 (2018), s. 66-74 $w MED00012667
856    41
$u https://jab.zsf.jcu.cz/pdfs/jab/2018/01/11.pdf $y plný text volně přístupný
910    __
$a ABA008 $b B 2301 $c 1249 $y 4 $z 0
990    __
$a 20180525144545 $b ABA008
991    __
$a 20180830183907 $b ABA008
999    __
$a ok $b bmc $g 1304771 $s 1015956
BAS    __
$a 3
BMC    __
$a 2018 $b 16 $c 1 $d 66-74 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
LZP    __
$c NLK125 $d 20180830 $a NLK 2018-22/dk

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...